Diet, Metabolism, and Disease / Diabetes, Cardiovascular Risks, and Lipoproteins / Nutrition, Genetics, and Disease · Journal article
Journal of Modern Medicine · August 11, 2026
A consensus or society position rather than new primary data.
This is a narrative review summarizing current clinical approaches to early identification of metabolic abnormalities and preventive strategies in individuals at high risk of type 2 diabetes. It describes diagnostic measures (fasting glucose, HbA1c, OGTT, BMI, waist circumference, lipid profile) and preventive interventions (diet, physical activity, weight reduction, sleep, lifestyle modification) but presents no original data, effect sizes, or comparative evidence to support change in practice.
Journal article. Individuals at high risk of type 2 diabetes mellitus.
Type 2 diabetes is characterized by a prolonged asymptomatic period during which insulin resistance and metabolic disturbances gradually develop Key diagnostic tools include fasting plasma glucose, glycated haemoglobin, oral glucose tolerance testing, body mass index, waist circumference, and lipid profile assessment Main preventive measures include balanced diet, increased physical activity, reduction of excess body weight, normalization of sleep, avoidance of harmful habits, and regular clinical follow-up
Main preventive measures include balanced diet, increased physical activity, reduction of excess body weight, normalization of sleep, avoidance of harmful habits, and regular clinical follow-up
This review articulates a systematic approach to screening and prevention in at-risk populations but does not provide quantified evidence of effectiveness. Clinicians should view this as a synthesis of established practice principles rather than new evidence to guide individual treatment decisions.
A narrative review article presenting current clinical approaches to early diagnosis and prevention of metabolic disorders in type 2 diabetes risk, without original research data or systematic evidence synthesis.
This review articulates a systematic approach to screening and prevention in at-risk populations but does not provide quantified evidence of effectiveness. Clinicians should view this as a synthesis of established practice principles rather than new evidence to guide individual treatment decisions.
Graded across the dimensions that decide whether you should act, each from what the source actually supports. There is no single score, and where a dimension was not assessed it says so.
What is missing. This record has no reported figures. That is a gap in the analysis, not a judgement about the study.
Type 2 diabetes mellitus is one of the most prevalent chronic diseases and is characterized by a prolonged asymptomatic period during which insulin resistance, disturbances of carbohydrate and lipid metabolism, abdominal obesity, and cardiovascular risk factors gradually develop. This article discusses current approaches to the early diagnosis and prevention of metabolic disorders in individuals at high risk of type 2 diabetes mellitus. Particular attention is paid to identifying hereditary predisposition, excess body weight, abdominal obesity, arterial hypertension, dyslipidaemia, insufficient physical activity, and unhealthy eating patterns. The diagnostic importance of fasting plasma glucose, glycated haemoglobin, oral glucose tolerance testing, body mass index, waist circumference, and lipid profile assessment is presented. The main preventive measures include a balanced diet, increased physical activity, reduction of excess body weight, normalization of sleep, avoidance of harmful habits, and regular clinical follow-up. Timely identification of early metabolic abnormalities and individualized correction of modifiable risk factors may improve tissue sensitivity to insulin, normalize carbohydrate metabolism, and reduce the likelihood of developing type 2 diabetes mellitus and its associated complications.
Taken from the source record, never inferred. Follow any of these and new work involving them reaches your briefing.